Ugene vs LabPlot
Side-by-side comparison for macOS
Ugene
8.0Free open-source cross-platform bioinformatics software
LabPlot
8.0Data visualization and analysis software
| Metric | Ugene | LabPlot |
|---|---|---|
| Category | Science | Science |
| AI Score | 8.0 | 8.0 |
| 30-day Installs | 10 | 71 |
| 90-day Installs | 18 | 207 |
| 365-day Installs | 59 | 634 |
| Version | 53.1 | 2.12.1 |
| Auto-updates | No | No |
| Deprecated | No | No |
| GitHub Stars | 261 | 445 |
| GitHub Forks | 68 | 58 |
| Open Issues | 16 | - |
| License | GPL-2.0 | — |
| Language | C++ | C++ |
| Last GitHub Commit | 2mo ago | 1mo ago |
| First Seen | Nov 4, 2021 | Aug 13, 2024 |
Reviews
Ugene
Ugene is a comprehensive bioinformatics tool designed for sequence analysis and editing. It offers a wide range of features for handling biological data, making it a valuable resource for researchers and biologists in the field of genomics and molecular biology.
Ugene provides tools for analyzing and editing biological sequences, supporting various formats and tasks in bioinformatics research.
Pros
- + Free and open-source, promoting accessibility and customization.
- + Supports multiple sequence formats, enhancing versatility.
- + Cross-platform compatibility, ensuring broad usability.
Cons
- - Lacks auto-update functionality, requiring manual checks for updates.
- - Limited community discussion, which may affect user support.
LabPlot
LabPlot is a versatile, open-source data visualization and analysis tool designed for everyone from students to professionals. It offers robust features for plotting and data manipulation, making it a valuable tool for scientific and engineering work.
LabPlot provides tools for data visualization, analysis, and manipulation, supporting a wide range of plotting options and data processing tasks.
Pros
- + Free and open-source, accessible to all users
- + Cross-platform support across multiple operating systems
- + Active development with recent updates and contributions
Cons
- - No auto-update feature for convenience
- - License information is unclear, which may concern users